303 related articles for article (PubMed ID: 32065978)
1. Cutaneous squamous cell carcinoma in the organ transplant recipient.
Bibee K; Swartz A; Sridharan S; Kurten CHL; Wessel CB; Skinner H; Zandberg DP
Oral Oncol; 2020 Apr; 103():104562. PubMed ID: 32065978
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
Cheng JY; Li FY; Ko CJ; Colegio OR
JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
[TBL] [Abstract][Full Text] [Related]
4. Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter study.
de Jong E; Genders R; Harwood CA; Green AC; Plasmeijer EI; Proby C; Geissler E; Ferrándiz-Pulido C; Ducroux E; Euvrard S; Geusau A; Jahn-Bassler K; Borik-Heil L; Rácz E; Nägeli M; Hofbauer GFL; Piaserico S; Russo I; Mackintosh L; Borges-Costa J; Angeliki-Gkini M; Zavattaro E; Savoia P; Imko-Walszuk B; Dębska-Slizień A; Garmyn M; van Kelst S; Ricar J; Cetkovska P; Matin R; Güleç AT; Seçkin D; Anene CA; Oliveira WRP; Rademaker M; Goeman J; van Geloven N; Ruiz E; Murad F; Karn E; Schmults CD; Bouwes Bavinck JN
J Am Acad Dermatol; 2024 Jun; 90(6):1200-1209. PubMed ID: 38301923
[TBL] [Abstract][Full Text] [Related]
5. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.
Massey PR; Schmults CD; Li SJ; Arron ST; Asgari MM; Bouwes Bavinck JN; Billingsley E; Blalock TW; Blasdale K; Carroll BT; Carucci JA; Chong AH; Christensen SR; Chung CL; DeSimone JA; Ducroux E; Escutia-Muñoz B; Ferrándiz-Pulido C; Fox MC; Genders RE; Geusau A; Gjersvik P; Hanlon AM; Olasz Harken EB; Hofbauer GFL; Hopkins RS; Leitenberger JJ; Loss MJ; Del Marmol V; Mascaró JM; Myers SA; Nguyen BT; Oliveira WRP; Otley CC; Proby CM; Rácz E; Ruiz-Salas V; Samie FH; Seçkin D; Shah SN; Shin TM; Shumack SP; Soon SL; Stasko T; Zavattaro E; Zeitouni NC; Zwald FO; Harwood CA; Jambusaria-Pahlajani A
JAMA Dermatol; 2021 Oct; 157(10):1219-1226. PubMed ID: 34468690
[TBL] [Abstract][Full Text] [Related]
6. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
[TBL] [Abstract][Full Text] [Related]
7. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients.
O'Reilly Zwald F; Brown M
J Am Acad Dermatol; 2011 Aug; 65(2):263-279. PubMed ID: 21763562
[TBL] [Abstract][Full Text] [Related]
8. rs34567942 a Novel Susceptibility Single Nucleotide Polymorphism for Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients.
Kuzmanov A; Qi W; Stenz N; Bochud PY; Kutalik Z; Wojtowicz A; Hofbauer G
Acta Derm Venereol; 2019 Dec; 99(13):1303-1304. PubMed ID: 31573663
[No Abstract] [Full Text] [Related]
9. Comment on "Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)".
Longo MI; Wen X; Womer KL
J Am Acad Dermatol; 2016 May; 74(5):e105-6. PubMed ID: 27085243
[No Abstract] [Full Text] [Related]
10. Increased Risk of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients and Patients on Chronic Dialysis: A Cancer Registry-based Study in Taiwan.
Tang CH; Sue YM; Hsieh WT; Wang YH; Wang CC
Acta Derm Venereol; 2019 Dec; 99(13):1275-1281. PubMed ID: 31631228
[TBL] [Abstract][Full Text] [Related]
11. Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: Population-based cohort study.
Chan AW; Fung K; Austin PC; Kim SJ; Singer LG; Baxter NN; Alhusayen R; Rochon PA
Am J Transplant; 2019 Feb; 19(2):522-531. PubMed ID: 29900669
[TBL] [Abstract][Full Text] [Related]
12. Skin cancer in transplant recipients: Scientific retreat of the international immunosuppression and transplant skin cancer collaborative and skin care in organ transplant patients-Europe.
Stevenson ML; Carucci J; Colegio OR
Clin Transplant; 2019 Dec; 33(12):e13736. PubMed ID: 31628869
[TBL] [Abstract][Full Text] [Related]
13. Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients.
Bakker D; Bakker WJ; Bekkenk MW; Luiten RM
Cells; 2023 Oct; 12(20):. PubMed ID: 37887285
[TBL] [Abstract][Full Text] [Related]
14. Updates in Skin Cancer in Transplant Recipients and Immunosuppressed Patients: Review of the 2022-2023 Scientific Symposium of the International Immunosuppression and Transplant Skin Cancer Collaborative.
Pisano C; Leitenberger JJ; Pugliano-Mauro M; Carroll BT
Transpl Int; 2024; 37():12387. PubMed ID: 38562207
[TBL] [Abstract][Full Text] [Related]
15. Skin and gut microbial associations with squamous cell carcinoma in solid organ transplant recipients.
Ha MV; McCormick TS; Salem I; Al-Shakhshir H; Ghannoum MA; Carroll BT
Arch Dermatol Res; 2023 Nov; 315(9):2709-2713. PubMed ID: 37278910
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and prevention strategies for cutaneous squamous cell carcinoma in transplant recipients.
Urso B; Kelsey A; Bordelon J; Sheiner P; Finch J; Cohen JL
Int J Dermatol; 2022 Oct; 61(10):1218-1224. PubMed ID: 35080249
[TBL] [Abstract][Full Text] [Related]
17. Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication.
Dusendang JR; Carlson E; Lee DS; Marwaha S; Madani S; Alexeeff SE; Webber A; Goes NB; Herrinton LJ
J Am Acad Dermatol; 2022 Mar; 86(3):598-606. PubMed ID: 34384835
[TBL] [Abstract][Full Text] [Related]
18. IRF4 Polymorphism Is Associated with Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients: A Pigment-Independent Phenomenon.
Asgari MM; Toland AE; Arron ST
J Invest Dermatol; 2017 Jan; 137(1):251-253. PubMed ID: 27566401
[No Abstract] [Full Text] [Related]
19. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients.
Herman S; Rogers HD; Ratner D
Skinmed; 2007; 6(5):234-8. PubMed ID: 17786101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
